The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).
 
Anuradha Krishnamurthy
No Relationships to Disclose
 
A. Dasari
No Relationships to Disclose
 
Anne M. Noonan
Consulting or Advisory Role - Helsinn Healthcare
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; EMD Serono; Merck; Merck
 
Albert C. Lockhart
Research Funding - Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Macrogenics (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst)
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst)
 
James J. Lee
Consulting or Advisory Role - Genentech
Research Funding - Merck
 
Aaron Richard Hansen
No Relationships to Disclose
 
Usha Malhotra
No Relationships to Disclose
 
Sarah Rippke
No Relationships to Disclose
 
Sarah Lindsey Davis
No Relationships to Disclose
 
Wells A. Messersmith
Consulting or Advisory Role - Gilead Sciences; Immunomedics; OncoMed
Research Funding - Immunomedics; Millennium; OncoMed; Pfizer; Roche/Genentech
 
S. Gail Eckhardt
Consulting or Advisory Role - CASI Pharmaceuticals; Champions Biotechnology; Kyowa Hakko Kirin; Lilly/ImClone; OnKure; Pfizer; Sanofi; Suvica; Taiho Pharmaceutical
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); cleave biosciences (Inst); Genentech (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Merck; Merrimack
Other Relationship - Immune Design